drug

SPARK

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by North Shore Therapeutics, Inc.
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

1
NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
NCT06653829—Completed

KOLs & investigators

1
Sunny X Tang, M.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
North Shore Therapeutics, Inc.
company
trial
NST-SPARK: Preliminary Study of an Augmented Reality (AR) App Delivering Recovery-Oriented Cognitive Therapy for Negative Symptoms in Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Negative Symptoms in Schizophrenia
indication
Psychotic Disorders
indication
KOL
Sunny X Tang, M.D.
KOL score —
person